Combination of fractional carbon dioxide laser with recombinant human collagen in periocular skin rejuvenation
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.15942 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Hui-Hui Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The East Division of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Laser Therapy, Lasers, Gas, Skin Aging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by the Guangdong Medical Science and Technology Research Project (A2021344) and Science and Technology Program of Jiangxi Provincial Heal….
Abstract (Originalsprache)
Background
The most visible sign of facial aging is often seen in the periocular area. However, periocular rejuvenation remains challenging due to the particularity of periocular anatomic locations.
Aims
We aimed to evaluate the efficacy and safety of the fractional‐ablative CO 2 laser‐facilitated recombinant human collagen permeation in periocular rejuvenation. Patients/Methods This 3‐month prospective single‐blinded and self‐controlled trial enrolled 26 patients with periocular aging who underwent the treatments of fractional‐ablative CO 2 laser along with laser‐facilitated recombinant human collagen permeation. Following the treatments, the patients were quantitatively assessed by various periocular skin aging indices before and after the treatment and monitored for any related adverse events.
Results
The patients showed significant improvements with the periocular skin aging indices 3 months after the treatments, which were detailed with a 47.3% decrease in lower eyelid skin rhytids, a 41.4% decrease in the lower eyelid skin texture, a 35.0% decrease in the static crow's feet, a 29.3% decrease in the amount of upper eyelid laxity, and a 20.2% increase in the MRD1 as compared with baseline ( p < 0.05). Moreover, total skin thickness under ultrasound was increased in both upper and lower eyelids (5.6% and 3.3%, p < 0.05, respectively). Moreover, six patients (23.1%, 6/26) had erythema for 2 weeks, and two (2/26, 7.7%) had mild hyperpigmentation for 3 months.
Conclusions
Fractional‐ablative CO 2 laser combined with laser‐facilitated recombinant human collagen permeation can be a safe and effective treatment for periocular rejuvenation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The East Division of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The East Division of The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Dermatology, The First Affiliated Hospital of Gannan Medical College, Ganzhou, China.
ORCID-Profile: Yu-Kun Zhao
Förderung
- This study was funded by the Guangdong Medical Science and Technology Research Project (A2021344) and Science and Technology Program of Jiangxi Provincial Heal…
Zitieren
APA
Wu, H. H., Chen, M. Q., Liu, J. H., Song, L. L., Luo, D. Q., Lu, J. F., & Zhao, Y. K. (2024). Combination of fractional carbon dioxide laser with recombinant human collagen in periocular skin rejuvenation. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15942
Vancouver
Wu HH, Chen MQ, Liu JH, Song LL, Luo DQ, Lu JF, et al. Combination of fractional carbon dioxide laser with recombinant human collagen in periocular skin rejuvenation. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.15942
BibTeX
@article{Wu2024,
author = {Wu, Hui-Hui and Chen, Mei-Qing and Liu, Juan-Hua and Song, Lu-Li and Luo, Di-Qing and Lu, Jing-Fa and Zhao, Yu-Kun},
title = {Combination of fractional carbon dioxide laser with recombinant human collagen in periocular skin rejuvenation},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.15942}
}
EUVIMED